Figure S5 from A Universal Boosting Strategy for Adoptive T-cell Therapy Using a Paired Vaccine/Chimeric Antigen Receptor

Rebecca Burchett; Claire G. Morris; Mira Ishak; Nickolas J. Serniuck; Derek T. Cummings; Christopher L. Baker; Ricardo M. Marius; Natasha Kazdhan; Christopher M. Silvestri; John Bell; Brian Dennis Lichty; Scott R. Walsh; Yonghong Wan; Joanne A. Hammill; Jonathan L. Bramson

doi:10.1158/2326-6066.31239044

Figure S5 from A Universal Boosting Strategy for Adoptive T-cell Therapy Using a Paired Vaccine/Chimeric Antigen Receptor

2026 Open access

Read full text

Authors: Rebecca Burchett, Claire G. Morris, Mira Ishak, Nickolas J. Serniuck, Derek T. Cummings, Christopher L. Baker, Ricardo M. Marius, Natasha Kazdhan, Christopher M. Silvestri, John Bell, Brian Dennis Lichty, Scott R. Walsh

+3 more

Yonghong Wan, Joanne A. Hammill, Jonathan L. Bramson

DOI: 10.1158/2326-6066.31239044

Cited by: 0

Abstract

Figure S5. Survival analysis following ACT/VSV vaccine combination therapy in the B16.F10-gp33 tumour model.

Fields of Study & Subjects

Immunotherapy and Immune Responses CAR-T cell therapy research Cancer Immunotherapy and Biomarkers

Publication details

Publication date: 3 February 2026